Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Displacement analysis of myocardial mechanical deformation (DIAMOND) reveals segmental susceptibility to doxorubicin-induced injury and regeneration
Junjie Chen, … , Tzung K. Hsiai, René R. Sevag Packard
Junjie Chen, … , Tzung K. Hsiai, René R. Sevag Packard
Published April 18, 2019
Citation Information: JCI Insight. 2019;4(8):e125362. https://doi.org/10.1172/jci.insight.125362.
View: Text | PDF
Resource and Technical Advance Cardiology

Displacement analysis of myocardial mechanical deformation (DIAMOND) reveals segmental susceptibility to doxorubicin-induced injury and regeneration

  • Text
  • PDF
Abstract

Zebrafish are increasingly utilized to model cardiomyopathies and regeneration. Current methods evaluating cardiac function have known limitations, fail to reliably detect focal mechanics, and are not readily feasible in zebrafish. We developed a semiautomated, open-source method — displacement analysis of myocardial mechanical deformation (DIAMOND) — for quantitative assessment of 4D segmental cardiac function. We imaged transgenic embryonic zebrafish in vivo using a light-sheet fluorescence microscopy system with 4D cardiac motion synchronization. Our method permits the derivation of a transformation matrix to quantify the time-dependent 3D displacement of segmental myocardial mass centroids. Through treatment with doxorubicin, and by chemically and genetically manipulating the myocardial injury–activated Notch signaling pathway, we used DIAMOND to demonstrate that basal ventricular segments adjacent to the atrioventricular canal display the highest 3D displacement and are also the most susceptible to doxorubicin-induced injury. Thus, DIAMOND provides biomechanical insights into in vivo segmental cardiac function scalable to high-throughput research applications.

Authors

Junjie Chen, Yichen Ding, Michael Chen, Jonathan Gau, Nelson Jen, Chadi Nahal, Sally Tu, Cynthia Chen, Steve Zhou, Chih-Chiang Chang, Jintian Lyu, Xiaolei Xu, Tzung K. Hsiai, René R. Sevag Packard

×

Figure 6

DIAMOND mechanics for segmental localization and quantification of NICD and NRG1 mRNA–mediated myocardial protection following doxorubicin-induced injury.

Options: View larger image (or click on image) Download as PowerPoint
DIAMOND mechanics for segmental localization and quantification of NICD ...
(A) Experimental schedule. (B and C) NICD and NRG1 mRNA microinjection rescued the reduction of myocardial displacement in segments I and VI by doxorubicin and γ-secretase inhibitor (DAPT) at 4 dpf. At 6 dpf, the inhibition of Notch signaling by DAPT impaired the restoration of segmental cardiac function (**P < 0.01 Dox vs. control; †P < 0.05, ††P < 0.01, Dox + DAPT vs. control, n = 6–10 per group). (D and E) Ejection fraction demonstrates at the global level that NICD and NRG1 mRNA micro-injection confers cardiac protection from doxorubicin-induced injury (ANOVA, *P < 0.05, **P < 0.01, n = 5–11 per group).

Copyright © 2022 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts